Form 4: Bausch Health Director Frank D. Lee Acquires 35,360 Shares Through RSU Grant

Director Frank D. Lee acquired 35,360 common shares of Bausch Health Companies Inc. through a restricted share unit (RSU) grant on May 17, 2024.

Summary

• On May 17, 2024, Frank D. Lee, a director of Bausch Health Companies Inc., acquired 35,360 common shares.
• The acquisition was through a grant of restricted share units (RSUs).
• The RSUs were granted to non-employee directors following their election at the Issuer's Annual Meeting of Shareholders.
• The grant date value of the RSUs is $250,000.
• The RSUs vest immediately prior to the Issuer's next Annual Meeting of Shareholders and are settled in common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of shares by a director is generally viewed as a positive sign, indicating confidence in the company. The RSU grant is a standard practice.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Future Outlook

The RSUs vest immediately prior to the Issuer's next Annual Meeting of Shareholders, indicating a future event tied to the company's annual cycle.

Industry Context

Directors receiving equity compensation is a common practice in publicly traded companies to align their interests with those of shareholders.

Comparison to Industry Standards

• RSUs are a standard form of equity compensation for directors in publicly traded companies, aligning their interests with shareholders.
• The grant date value of $250,000 is within a typical range for director compensation at companies of similar size and industry to Bausch Health.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Next Steps

• The RSUs will vest immediately prior to the Issuer's next Annual Meeting of Shareholders.

Key Dates